4,5-dicyanoimidazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

imidazole-4,5-dicarbonitrile: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	70729
SCHEMBL ID	20204
MeSH ID	M0287208

Synonyms (44)

Synonym
nsc113954
1122-28-7
nsc-113954
imidazole-4,5-dicarbonitrile
1h-imidazole, 1-(1h-imidazol-1-ylsulfonyl)-
inchi=1/c5h2n4/c6-1-4-5(2-7)9-3-8-4/h3h,(h,8,9
4,5-dicyanoimidazole, 99.0%
4,5-dicyanoimidazole, 95%
AC-3058
STL001786
1h-imidazole-4,5-dicarbonitrile
4,5-dicyanoimidazole
4,5-imidazoledicarbonitrile
D2026
AKOS002240570
1h-imidazol-4,5-dikohlenitrile
EN300-77565
az5x73c3cc ,
unii-az5x73c3cc
nsc 113954
einecs 214-344-6
c5h2n4
FT-0617175
PS-3323
F3308-1854
4,5-dicyanoimidazole in anhydrous acetonitril
BP-21384
imidazole-4,5-dinitrile
AM83819
BBL027504
SCHEMBL20204
STR00733
Q-100973
moa 7
mfcd00005194
DTXSID00149943
CS-W001962
19485-44-0
SB30709
AMY23389
4,5-dicyanoimidazole (dci)
4,5-diccyanoimidazole
A925593
HY-W001962

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	1 (10.00)	18.2507
2000's	3 (30.00)	29.6817
2010's	6 (60.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	29.75 (24.57)
Research Supply Index	2.40 (2.92)
Research Growth Index	4.96 (4.65)
Search Engine Demand Index	34.37 (26.88)
Search Engine Supply Index	2.00 (0.95)

This Compound (29.75)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	10 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
adenine [no description available]	2.01	1	6-aminopurines; purine nucleobase	Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
imidazole imidazole: RN given refers to parent cpd. 1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.	7.05	1	imidazole
purine 1H-purine : The 1H-tautomer of purine.. 3H-purine : The 3H-tautomer of purine.. 9H-purine : The 9H-tautomer of purine.. 7H-purine : The 7H-tautomer of purine.	7.07	1	purine
uridine [no description available]	7.21	1	uridines	drug metabolite; fundamental metabolite; human metabolite
piperidine [no description available]	2.21	1	azacycloalkane; piperidines; saturated organic heteromonocyclic parent; secondary amine	base; catalyst; human metabolite; non-polar solvent; plant metabolite; protic solvent; reagent
1,2,4-triazole 1,2,4-triazole: RN given refers to 1H-1,2,4-triazole	7.07	1	1,2,4-triazole
phosphoramidic acid phosphoramidic acid: urease inhibitor; RN given refers to parent cpd; structure; do not confuse with phosphoramidites, which are organophosphorus compounds	2.08	1	phosphoric acid derivative
triazoles Triazoles: Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3.. triazoles : An azole in which the five-membered heterocyclic aromatic skeleton contains three N atoms and two C atoms.	2.07	1	1,2,3-triazole
1h-tetrazole tetrazole : An azaarene that is a five-membered ring composed of 4 nitrogen and 1 carbon atom.. 2H-tetrazole : A tetrazole tautomer where the proton is located on the 2 position.	7.41	2	one-carbon compound; tetrazole
arabinose [no description available]	2.21	1	L-arabinose	Escherichia coli metabolite; mouse metabolite
arabinofuranose arabinofuranose: structure in first source. L-arabinofuranose : The five-membered ring form of L-arabinose.	2.21	1	L-arabinose
oligonucleotides [no description available]	1.99	1
piperidines Piperidines: A family of hexahydropyridines.	2.21	1
warfarin Warfarin: An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.. warfarin : A racemate comprising equal amounts of (R)- and (S)-warfarin. Extensively used as both an anticoagulant drug and as a pesticide against rats and mice.. 4-hydroxy-3-(3-oxo-1-phenylbutyl)-1-benzopyran-2-one : A member of the class of coumarins that is 4-hydroxycoumarin which is substituted at position 3 by a 1-phenyl-3-oxo-1-butyl group.	2.07	1	benzenes; hydroxycoumarin; methyl ketone

Condition	Indicated	Relationship Strength	Studies	Trials
Benign Neoplasms [description not available]	0	2.07	1	0
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	0	2.07	1	0

chemdatabank.com